Remove 2006 Remove Documentation Remove Drug Pricing
article thumbnail

Independents Outshine PBMs in Manufacturers’ Exclusive Specialty Pharmacy Networks (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. Click here to see the original post from April 2024.

article thumbnail

Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (Video)

Drug Channels

I then document how five multi-billion-dollar, for-profit, publicly traded pharmacy chains and pharmacy benefit managers (PBMs)—Cigna (via Express Scripts), CVS Health, UnitedHealth Group (via OptumRx), and Walgreens, Walmart—continue to dominate the 340B contract pharmacy market. Click here if you can’t see the video below.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PBM-Owned Specialty Pharmacies Expand Their Role In—and Profits From—the 340B Program

Drug Channels

Last week, I documented that nearly half of U.S. pharmacies now participate in the 340B Drug Pricing Program. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

article thumbnail

NEW: The 2021 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

Drug Channels

Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: The Latest Trends for U.S. Drug Pricing, Reimbursement, and Patient Costs (press release) We’re offering special discounted pricing if you order before March 28, 2021.

article thumbnail

NOW AVAILABLE: The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

Drug Channels

drug pricing, reimbursement, and dispensing system. There are loads of internal hyperlinks to help you navigate the document and customize it to your specific interests and priorities. Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. The 2022 Economic Report on U.S.

article thumbnail

Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (rerun)

Drug Channels

This week, Im rerunning some popular posts while I prepare for Fridays Drug Channels Outlook 2025 live video webinar. 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Click here to see the original post. In the video excerpt below, I walk through a brief history of 340B contract pharmacies.